PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.

Authors

null

Matthew David Lashey

Treatment Technologies and Insights, Inc., El Segundo, CA

Matthew David Lashey , Estefania Linares Espinos , Laura Basterretxea , Ibon Gurruchaga , Borja Gomez Mediavilla , Brigida Esteban , Diego Cacho , Belen Congregado , Ines Rivero Belenchon , Amaia Hernandez , Gemma Sancho , Nuria Lainez , David Buchser , Francesco Sanguedolce , Ignacio Duran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Other Technology and Innovations

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 192)

DOI

10.1200/JCO.2024.42.23_suppl.192

Abstract #

192

Poster Bd #

K10

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.

PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform.

First Author: Diego Cacho

First Author: Katherine Barnhill

Poster

2023 ASCO Genitourinary Cancers Symposium

Contemporary use of wearable activity monitors in prostate cancer survivors: A scoping review.

Contemporary use of wearable activity monitors in prostate cancer survivors: A scoping review.

First Author: Brandon Noorvash